Proteomics International is pleased to share a copy of the Investor Webinar and Q&A session held on October 3, 2023. The webinar hosted by Dr Richard Lipscombe, Managing Director of Proteomics International, covers the recent announcement regarding PromarkerD US reimbursement price and the Australian regulatory decision.
